| Product NDC: | 55390-113 |
| Proprietary Name: | Phentolamine Mesylate |
| Non Proprietary Name: | Phentolamine Mesylate |
| Active Ingredient(s): | 5 mg/mL & nbsp; Phentolamine Mesylate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55390-113 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040235 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19980515 |
| Package NDC: | 55390-113-01 |
| Package Description: | 1 VIAL in 1 BOX (55390-113-01) > 1 mL in 1 VIAL |
| NDC Code | 55390-113-01 |
| Proprietary Name | Phentolamine Mesylate |
| Package Description | 1 VIAL in 1 BOX (55390-113-01) > 1 mL in 1 VIAL |
| Product NDC | 55390-113 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Phentolamine Mesylate |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 19980515 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | PHENTOLAMINE MESYLATE |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |